Prediction of S-1 adjuvant chemotherapy benefit in Stage II/III gastric cancer treatment based on comprehensive gene expression analysis

被引：0
|
作者：
Kenichi Nakamura
Keiichi Hatakeyama
Kenichiro Furukawa
Keiichi Fujiya
Satoshi Kamiya
Makoto Hikage
Yutaka Tanizawa
Etsuro Bando
Keiichi Ohshima
Kenichi Urakami
Nozomu Machida
Hirofumi Yasui
Ken Yamaguchi
Masanori Terashima
机构：
[1] Shizuoka Cancer Center,Division of Gastric Surgery
[2] Shizuoka Cancer Center,Medical Genetics Division, Research Institute
[3] Shizuoka Cancer Center,Cancer Diagnostics Research Division, Research Institute
[4] Shizuoka Cancer Center,Division of Gastrointestinal Oncology
[5] Shizuoka Cancer Center,Research Institute
来源：
Gastric Cancer | 2020年 / 23卷
关键词：
Adjuvant drug therapy; Gastric cancer; Drug response biomarker; Gene expression profiling;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：648 / 658
页数：10
相关论文
共 50 条
  • [1] Prediction of S-1 adjuvant chemotherapy benefit in Stage II/III gastric cancer treatment based on comprehensive gene expression analysis
    Nakamura, Kenichi
    Hatakeyama, Keiichi
    Furukawa, Kenichiro
    Fujiya, Keiichi
    Kamiya, Satoshi
    Hikage, Makoto
    Tanizawa, Yutaka
    Bando, Etsuro
    Ohshima, Keiichi
    Urakami, Kenichi
    Machida, Nozomu
    Yasui, Hirofumi
    Yamaguchi, Ken
    Terashima, Masanori
    GASTRIC CANCER, 2020, 23 (04) : 648 - 658
  • [2] Survival analysis of adjuvant chemotherapy with S-1 plus cisplatin for stage III gastric cancer
    Takahari, Daisuke
    Hamaguchi, Tetsuya
    Yoshimura, Kenichi
    Katai, Hitoshi
    Ito, Seiji
    Fuse, Nozomu
    Konishi, Masaru
    Yasui, Hirofumi
    Terashima, Masanori
    Goto, Masahiro
    Tanigawa, Nobuhiko
    Shirao, Kuniaki
    Sano, Takeshi
    Sasako, Mitsuru
    GASTRIC CANCER, 2014, 17 (02) : 383 - 386
  • [3] Impact of the ESM-1 Gene Expression on Outcomes in Stage II/III Gastric Cancer Patients Who Received Adjuvant S-1 Chemotherapy
    Kano, Kazuki
    Sakamaki, Kentaro
    Oue, Naohide
    Kimura, Yayoi
    Hashimoto, Itaru
    Hara, Kentaro
    Maezawa, Yukio
    Aoyama, Toru
    Fujikawa, Hirohito
    Hiroshima, Yukihiko
    Yamada, Takanobu
    Tamagawa, Hiroshi
    Yamamoto, Naoto
    Ogata, Takashi
    Cho, Haruhiko
    Ito, Hiroyuki
    Shiozawa, Manabu
    Yukawa, Norio
    Yoshikawa, Takaki
    Morinaga, Soichiro
    Rino, Yasushi
    Yasui, Wataru
    Masuda, Munetaka
    Miyagi, Yohei
    Oshima, Takashi
    IN VIVO, 2020, 34 (01): : 461 - 467
  • [4] Survival analysis of adjuvant chemotherapy with S-1 plus cisplatin for stage III gastric cancer
    Daisuke Takahari
    Tetsuya Hamaguchi
    Kenichi Yoshimura
    Hitoshi Katai
    Seiji Ito
    Nozomu Fuse
    Masaru Konishi
    Hirofumi Yasui
    Masanori Terashima
    Masahiro Goto
    Nobuhiko Tanigawa
    Kuniaki Shirao
    Takeshi Sano
    Mitsuru Sasako
    Gastric Cancer, 2014, 17 : 383 - 386
  • [5] Phase II feasibility study of adjuvant chemotherapy with docetaxel/cisplatin/S-1 followed by S-1 for stage III gastric cancer
    Noriyuki Hirahara
    Takeshi Matsubara
    Shunsuke Kaji
    Tetsu Yamamoto
    Ryoji Hyakudomi
    Kiyoe Takai
    Kazunari Ishitobi
    Yuki Uchida
    Yoshitsugu Tajima
    BMC Cancer, 21
  • [6] Phase II feasibility study of adjuvant chemotherapy with docetaxel/cisplatin/S-1 followed by S-1 for stage III gastric cancer
    Hirahara, Noriyuki
    Matsubara, Takeshi
    Kaji, Shunsuke
    Yamamoto, Tetsu
    Hyakudomi, Ryoji
    Takai, Kiyoe
    Ishitobi, Kazunari
    Uchida, Yuki
    Tajima, Yoshitsugu
    BMC CANCER, 2021, 21 (01)
  • [7] Tolerability of adjuvant chemotherapy with S-1 after curative resection in patients with stage II/III gastric cancer
    Tsujimoto, Hironori
    Horiguchi, Hiroyuki
    Hiraki, Shuichi
    Yaguchi, Yoshihisa
    Takahata, Risa
    Kumano, Isao
    Yoshida, Kazumichi
    Matsumoto, Yusuke
    Ono, Satoshi
    Yamamoto, Junji
    Hase, Kazuo
    ONCOLOGY LETTERS, 2012, 4 (05) : 1135 - 1139
  • [8] Adjuvant Chemotherapy With S-1 Plus Docetaxel Versus S-1 Plus Oxaliplatin in Stage III Gastric Cancer
    Yamamoto, Masaaki
    Omori, Takeshi
    Shinno, Naoki
    Hara, Hisashi
    Mukai, Yosuke
    Sugase, Takahito
    Takeoka, Tomohira
    Mikamori, Manabu
    Kanemura, Takashi
    Hasegawa, Shinichiro
    Akita, Hirofumi
    Haraguchi, Naotsugu
    Nishimura, Junichi
    Wada, Hiroshi
    Matsuda, Chu
    Yasui, Masayoshi
    Miyata, Hiroshi
    Ohue, Masayuki
    ANTICANCER RESEARCH, 2023, 43 (11) : 5015 - 5024
  • [9] Outcome predictors for patients with stage II/III gastric cancer who undergo gastrectomy and S-1 adjuvant chemotherapy
    Fujiwara, Yoshinori
    Fukuda, Shuichi
    Tsujie, Masanori
    Kitani, Kotaro
    Inoue, Keisuke
    Hayashi, Tomonori
    Ishikawa, Hajime
    Yukawa, Masao
    Inoue, Masatoshi
    ONCOLOGY LETTERS, 2017, 14 (02) : 1621 - 1627
  • [10] Comparison of PSOX (paclitaxel, oxaliplatin, S-1) and SOX (oxaliplatin, S-1) as postoperative adjuvant chemotherapy for stage II-III gastric cancer
    Wang, Fei-Yu
    Huang, Xiang-Ming
    Cao, Yu-Qing
    Cao, Jie
    Song, Meng
    Fang, Zhi-Jun
    Huang, Xin-En
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2025, 23 (01)
12345